Tilray Brands, Inc. (NASDAQ:TLRY) is a prominent player in the cannabis industry, known for its diverse range of cannabis products. The company operates in a competitive market alongside other major cannabis firms. As TLRY prepares to release its quarterly earnings on July 28, 2025, investors are keenly watching the anticipated financial results.
Wall Street estimates that TLRY will report an earnings per share (EPS) of -$0.03. This represents a 25% improvement from the same period last year, as highlighted by the company's expected quarterly loss. Despite the negative EPS, the improvement suggests that TLRY is making strides towards better financial health.
Revenue projections for TLRY are approximately $233.3 million, with some estimates reaching $240 million, indicating a 4.4% year-over-year increase. This growth in revenue reflects the company's efforts to expand its market presence and increase sales, even as the cannabis industry faces various challenges.
The stability in the consensus EPS estimate over the past 30 days suggests that analysts have maintained their initial projections. This stability is important as revisions to earnings estimates can influence investor behavior and impact short-term stock price movements.
TLRY's financial ratios provide insight into its current financial position. The company has a price-to-earnings (P/E) ratio of -0.68, indicating it is not yet profitable. However, a price-to-sales ratio of 0.88 suggests the stock is valued at less than one times its sales, which may appeal to value investors. The enterprise value to sales ratio of 1.06 and the enterprise value to operating cash flow ratio of -17.24 highlight challenges in generating positive cash flow. Despite these challenges, TLRY maintains a strong liquidity position with a current ratio of 2.62, indicating its ability to cover short-term liabilities.
